FORWARD FEATURES CALENDAR

Find us on

Latest News

Catapult Ventures, manager of the GM&C Life Sciences Fund, has made an investment in YProTech, a high value chemistry services company based in Alderley Park, Cheshire. The investment will enable YProTech to commission a high-potency facility at Alderley Park, to extend its range of high value services and strengthen its sales and marketing capability.   The investment builds on Catapult Ventures’ previous record of investing in contract research organisations (CRO), having backed R5 Pharmaceuticals, which was bought by Aesica, and more recently, Food and Drug Analytical Services (FDAS), which was bought by Tentamus Group in April.    Tony Flinn who
AREAM and Greentale Capital have established a joint venture that will leverage the combined experience of two teams in the renewable energy and investment management industries. The joint venture will assist institutional investors to gain high-quality exposure to investment opportunities in the renewable energy industry.   Initially, the joint venture will provide specialised investment management and fundraising advisory services to a forthcoming investment vehicle, which will enable institutional investors to seize significant returns while simultaneously diversifying their portfolios by investing in the renewable energy industry.   AREAM has been investing in renewable energy for over 10 years, constructing, acquiring and
IFC, a member of the World Bank Group, has launched a programme that aims to raise USD5 billion from global institutional investors to modernise infrastructure in emerging markets over the next five years. The new platform will look to open up a new stream of capital flows to improve power, water, transportation and telecommunications systems in developing countries.   The initiative, called MCPP Infrastructure, builds on IFC’s Managed Co-Lending Portfolio Program, a loan-syndications initiative that enables third-party investors to participate passively in IFC’s senior loan portfolio. In its first phase, the programme allocated USD3 billion from the People’s Bank of
Arnaud Fromion and Frédéric Guilloux are joining Goodwin’s private equity practice in Paris as partners in mid-October, together with counsel Adrien Paturaud and several associates. The group comes to Goodwin from Shearman & Sterling.   The team specialises in acquisition finance and corporate finance, acting for both lenders and borrowers, and private equity sponsors. They have represented numerous financial institutions, banks, private debt funds and borrowers on a broad range of leveraged finance transactions, including unirate bond financings. The team also acts for lenders and borrowers on large corporate, “crossover” and telecom financings.   “We are delighted that Arnaud and
One UK start-up will receive GBP150,000 every month for the next 12 months as part of the Start-Up Series, a new competition offering GBP1.8m in seed funding. Winners will be made aware just eight weeks from their date of application, with funds received within 12 weeks.   Launched by Worth Capital in partnership with Startups.co.uk, the Start-Up Series is the UK’s biggest ever seed investment competition, giving young businesses a chance to apply for a share of the GBP1.8 million investment pot.   From every month’s competition, one winning business will be selected to be put forward for up to
Bowmark Capital, a mid-market private equity firm, is backing the buy-out of IT solutions provider Node4 Holdings from its previous institutional investor, LDC.  Founded in Derby in 2004 by its then 23 year old chief executive Andrew Gilbert, Node4 is a provider of integrated IT solutions, hybrid infrastructure and cloud-enabled managed services to small and medium-sized businesses.   With full ownership of its own infrastructure, including three state-of-the-art data centres in Derby, Leeds and Northampton, Node4 retains full control over service delivery.   The company achieved a GBP28 million turnover in the year to March 2016 and a revenue growth
IK Investment Partners’ IK Small Cap I Fund is to acquire APOSAN Dr Künzer, a pharmaceutical homecare company in Germany. Financial terms of the transaction have not been disclosed.   APOSAN was founded in 1991 by Dr Clemens Künzer, with the purpose to service homecare patients through the compounding of individualised infusible and injectable medication.   Since then, the company has evolved to an integrated full-range pharmaceutical homecare supplier with its own manufacturing capacities and a dedicated key account management and homecare nurses team to generate and support its growing nationwide patient base.   The APOSAN group of companies is
The Bridges Sustainable Growth Fund III (SGF III), managed by specialist sustainable and impact investor Bridges Ventures, has invested in Vegetarian Express (VE), a supplier of plant-based food ingredients. Bridges has invested GBP5.6 million to take a controlling interest in VE. It will work in partnership with current shareholders David Jonas (founder of the business in 1987) and Will Matier, both of whom will remain actively involved with the business. In addition, Tim Kelly, former COO of Premier Foods, joins VE as executive chairman.   Based in Watford, VE is a supplier of specialist plant-based ingredients to the food service
DiCentral, a provider of supply chain management solutions and B2B integration, has completed a USD15 million Series A financing led by Kayne Partners, the growth private equity group of Kayne Anderson Capital Advisors. The capital will be used to accelerate the organic growth and acquisition strategy of the supply chain management services provider.   “DiCentral has a rich 16-year history of self-funding our growth. Although we have had many offers over the years to take in investment money, we never felt it was the right partnership,” says Thuy Mai, CEO and founder of DiCentral. “Now is the right opportunity and
Affiliated Managers Group (AMG) has bought interests in Winton Group and Partner Fund Management (PFM). Founded in 1997, Winton is a global investment manager that uses scientific methods to develop investment systems across a broad range of products from diversified multi-asset offerings to regional long-only equities.   The firm is headquartered in London and has over 400 employees, with additional offices in Oxford, Zurich, Hong Kong, Shanghai, New York, Tokyo, Sydney, and San Francisco.   PFM manages global equity strategies, including global diversified long/short, global long, and global healthcare funds. PFM was founded in 2004 and is based in San Francisco.

Special Reports

Featured

Events

12 November, 2026 – 8:00 am

Directory Listings